{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:21:43Z","timestamp":1780694503990,"version":"3.54.1"},"reference-count":70,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Opioid use disorder (OUD) is highly prevalent among persons who are incarcerated. Medication treatment for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, is widely used to treat OUD in the community. Despite MOUD's well-documented effectiveness in improving health and social outcomes, its use in American jails and prisons is limited.<\/jats:p>\n                  <jats:p>Several factors are used to justify limited access to MOUD in jails and prisons including: \u201cuncertainty\u201d of MOUD's effectiveness during incarceration, security concerns, risk of overdose from MOUD, lack of resources and institutional infrastructure, and the inability of people with OUD to provide informed consent. Stigma regarding MOUD also likely plays a role. While these factors are relevant to the creation and implementation of addiction treatment policies in incarcerated settings, their ethicality remains underexplored.<\/jats:p>\n                  <jats:p>Using ethical principles of beneficence\/non-maleficence, justice, and autonomy, in addition to public health ethics, we evaluate the ethicality of the above list of factors. There is a two-fold ethical imperative to provide MOUD in jails and prisons. Firstly, persons who are incarcerated have the right to evidence-based medical care for OUD. Secondly, because jails and prisons are government institutions, they have an obligation to provide that evidence-based treatment. Additionally, jails and prisons must address the systematic barriers that prevent them from fulfilling that responsibility. According to widely accepted ethical principles, strong evidence supporting the health benefits of MOUD cannot be subordinated to stigma or inaccurate assessments of security, cost, and feasibility. We conclude that making MOUD inaccessible in jails and prisons is ethically impermissible.<\/jats:p>","DOI":"10.1080\/08897077.2019.1695706","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T13:24:50Z","timestamp":1575465890000},"page":"150-154","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["An Ethical Analysis of Medication Treatment for Opioid use Disorder (MOUD) for Persons who are Incarcerated"],"prefix":"10.1177","volume":"41","author":[{"given":"Emma R.","family":"Brezel","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Montefiore Medical Center, New York, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia","family":"Powell","sequence":"additional","affiliation":[{"name":"Montefiore-Einstein Center for Bioethics, Montefiore Medical Center, New York, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Montefiore Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2007.0021"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0558"},{"key":"e_1_3_1_4_2","unstructured":"Lopez G. How America's prisons are fueling the opioid epidemic. Vox Media. https:\/\/www.vox.com\/policy-and-politics\/2018\/3\/13\/17020002\/prison-opioid-epidemic-medications-addiction. Published 2018. Accessed September 22 2019."},{"key":"e_1_3_1_5_2","unstructured":"WHO Model List of Essential Medicines. https:\/\/www.who.int\/medicines\/publications\/essentialmedicinesEML_2015_FINAL_amended_NOV2015.pdf. Published 2015. Accessed September 22 2019."},{"key":"e_1_3_1_6_2","unstructured":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. World Health Organization https:\/\/www.who.int\/substance_abuse\/publications\/opioid_dependence_guidelines.pdf. Published 2009. Accessed September 22 2019."},{"key":"e_1_3_1_7_2","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63 Full Document. HHS Publication No. (SMA) 19-5063FULLDOC. Rockville MD: Substance Abuse and Mental Health Services Administration; 2018."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.12.003"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03676.x"},{"key":"e_1_3_1_10_2","unstructured":"Vestal C. New Momentum for Addiction Treatment Behind Bars. The Pew Chartiable Trusts. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/blogs\/stateline\/2018\/04\/04\/new-momentum-for-addiction-treatment-behind-bars. Published 2018. Accessed May 19 2019."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1073110518782926"},{"key":"e_1_3_1_12_2","unstructured":"Backus L. Funding to help CT prisons improve opioid addiction treatment program. The Middletown Press. https:\/\/www.middletownpress.com\/middletown\/article\/Funding-to-help-CT-prisons-improve-opioid-14069347.php. Published 2019. Accessed September 19 2019."},{"key":"e_1_3_1_13_2","unstructured":"Faher M. More than 500 Vermon inmates recieving addiction treatment VTDigger. https:\/\/vtdigger.org\/2019\/01\/23\/500-vermont-inmates-receiving-addiction-treatment\/. Published 2019. Accessed September 19 2019."},{"key":"e_1_3_1_14_2","unstructured":"Vestal C. At Rikers Island a Legacy of Medication-Assisted Opioid Treatment. The Pew Charitable Trusts. https:\/\/www.pewtrusts.org\/en\/researchandanalysis\/blogs\/stateline\/2016\/05\/23\/at-rikers-island-a-legacy-of-medicationassisted-opioid-treatment. Published 2016. Accessed September 19 2019."},{"key":"e_1_3_1_15_2","unstructured":"Jones L. New York State Must Take Action to Reduce Opioid Overuse Deaths. Vera Institute of Justice. Think Justic Blog Web site. https:\/\/www.vera.org\/blog\/new-york-statemust-take-action-to-reduce-opioid-overuse-deaths. Published 2019. Accessed September 19 2019."},{"key":"e_1_3_1_16_2","unstructured":"Governor Baker Signs Second Major Piece of Legislation to Address Opioid Epidemic in Massachusetts. Commonwealth of Massachusets. https:\/\/www.mass.gov\/news\/governor-baker-signs-second-major-piece-of-legislation-to-address-opioid-epidemic-in. Published 2018. Accessed October 6 2019."},{"key":"e_1_3_1_17_2","unstructured":"Governor Murphy Announces New Initiatives to Combat the Opioid Epidemic. State of New Jersey. https:\/\/www.nj.gov\/governor\/news\/news\/562019\/approved\/20190123b.shtml. Published 2019. Accessed October 6 2019."},{"key":"e_1_3_1_18_2","unstructured":"Friederich R. Corrections Takes Steps to Help Curb State's Opioid Epidemic. Washington State Department of Corrections. https:\/\/www.doc.wa.gov\/news\/2018\/11132018.htm. Published 2018. Accessed May 19 2019."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.06.015"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0024"},{"key":"e_1_3_1_21_2","unstructured":"Public Policy Statement: Definition of Addiction American Soceity of Addiction Medicine. https:\/\/www.asam.org\/docs\/default-source\/public-policystatements\/1definition_of_addiction_long_4-11.pdf?sfvrsn=a8f64512_4. Published 2011. Accessed September 21 2019."},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.5523"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1363238"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/16066350512331328159"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.soc.27.1.363"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.2190\/M11W-VWXE-KQM9-G97Q"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.10.014"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2147"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.611460"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.10.004"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jti072"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12317"},{"key":"e_1_3_1_33_2","unstructured":"Goodnough A Zezima K. When Children's Scribbles Hide a Prison Drug. The New York Times. https:\/\/www.nytimes.com\/2011\/05\/27\/us\/27smuggle.html. Published 2011. Accessed September 27 2019."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6612a2"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000045"},{"key":"e_1_3_1_36_2","unstructured":"Coll S. The jail health-care crisis. Conde Nast. https:\/\/www.newyorker.com\/magazine\/2019\/03\/04\/the-jail-health-care-crisis. Published 2019. Accessed 09\/22 2019."},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1525\/fsr.2012.25.1.68"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.06.009"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2002.tb00722.x"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1162\/152651602317533695"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1162\/152651602317533686"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.08.015"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2003.09.009"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.7.737"},{"key":"e_1_3_1_45_2","volume-title":"Principles of Biomedical Ethics","author":"Beauchamp TLC","year":"2009","unstructured":"Beauchamp TLC, , James F. Principles of Biomedical Ethics. New York: Oxford University Press; 2009."},{"key":"e_1_3_1_46_2","unstructured":"U.S. Department of Health and Human Services (HHS) Office of the Surgeon General. Facing addiction in America: the surgeon general's spotlight on opioids. https:\/\/addiction.surgeongeneral.gov\/sites\/default\/files\/Spotlight-on-Opioids_09192018.pdf. Published 2018. Accessed September 22 2019."},{"key":"e_1_3_1_47_2","unstructured":"American Correctional Association and American Society of Addiction Medicine Release Joint Policy Statement on Opioid Use Disorder Treatment in the Justice System. American Correctional Association. https:\/\/www.aca.org\/ACA_Prod_IMIS\/DOCS\/ACA-ASAM Press Release and Joint Policy Statement 3.20.18.pdf. Published 2019. Accessed September 23 2019."},{"key":"e_1_3_1_48_2","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick RP","year":"2003","unstructured":"Mattick RP, , Breen C, , Kimber J, , Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;(2):CD002209.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_49_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"3","author":"Mattick RP","year":"2004","unstructured":"Mattick RP, , Breen C, , Kimber J, , Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2004;(3):CD002207.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13779"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2006.018077"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.08.006"},{"key":"e_1_3_1_53_2","unstructured":"National Institute on Drug Abuse. Treating Opioid Addiction in Criminal Justice Settings National Institute on Drug Abuse. https:\/\/d14rmgtrwzf5a.cloudfront.net\/sites\/default\/files\/policybrief-cj.pdf. Published 2017. Accessed September 21 2019."},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6526a2"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.09.007"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078345813518629"},{"issue":"4","key":"e_1_3_1_57_2","first-page":"472","article-title":"Prescribing opioid replacement therapy in US correctional settings","volume":"45","author":"Farahmand P","year":"2017","unstructured":"Farahmand P, , Modesto-Lowe V, , Chaplin MM. Prescribing opioid replacement therapy in US correctional settings. J Am Acad Psychiatry Law 2017;45(4):472\u2013477.","journal-title":"J Am Acad Psychiatry Law"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.9289"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-1225-0"},{"key":"e_1_3_1_60_2","unstructured":"Estelle v. Gamble 429\u2009U.S. 97 (1976). Justia. https:\/\/supreme.justia.com\/cases\/federal\/us\/429\/97\/#tab-opinion-1952035. Accessed October 22 2019."},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078345807309616"},{"key":"e_1_3_1_62_2","first-page":"175","article-title":"United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules)","volume":"70","author":"Assembly UG","year":"2015","unstructured":"Assembly UG. United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). UN GA Res 2015;70:175.","journal-title":"UN GA Res"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.09.007"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/bsl.707"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.06.003"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2002.tb00384.x"},{"key":"e_1_3_1_67_2","unstructured":"Hughes T James Wilson D. Reentry Trends in the United States. Bureau of Justice Statistics. https:\/\/www.bjs.gov\/content\/reentry\/reentry.cfm. Published 2019. Accessed September 27 2019."},{"key":"e_1_3_1_68_2","unstructured":"Why does heroin use create special risk for contracting HIV\/AIDS and hepatitis B and C? National Institute on Drug Abuse. https:\/\/www.drugabuse.gov\/publications\/research-reports\/heroin\/why-are-heroin-users-special-risk-contracting-hivaids-hepatitis-b-c. Published 2018. Accessed September 2 2019."},{"key":"e_1_3_1_69_2","unstructured":"National Institute on Drug Abuse. Principles of drug abuse treatment for criminal justice populations \u2013 a research-based guide. National Institute of Drug Abuse. https:\/\/d14rmgtrwzf5a.cloudfront.net\/sites\/default\/files\/txcriminaljustice_0.pdf. Published 2014. Accessed September 23 2019."},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02826.x"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0400-5"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1695706","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1695706","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1695706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:00:09Z","timestamp":1780491609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1695706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1080\/08897077.2019.1695706"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1695706","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}